cobicistat / elvitegravir / emtricitabine / tenofovir alafenamide Pill

RxNorm concept 1721610, clinical dose form group (scdg).

RxCUI: 1721610
Term type: Clinical dose form group (SCDG)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/1721610 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

Related concepts

emtricitabine (IN, has ingredient)
cobicistat (IN, has ingredient)
elvitegravir (IN, has ingredient)
tenofovir alafenamide (IN, has ingredient)
Genvoya Pill (SBDG, has tradename)

Linked data

NDCs

RxNorm links no NDCs to this concept.

Use it

Look up 1721610 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/1721610 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 1721610. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.